Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate. 2010

Hanne Schoenen, and Barbara Bodendorfer, and Kelly Hitchens, and Silvia Manzanero, and Kerstin Werninghaus, and Falk Nimmerjahn, and Else Marie Agger, and Steffen Stenger, and Peter Andersen, and Jürgen Ruland, and Gordon D Brown, and Christine Wells, and Roland Lang
Institute of Clinical Microbiology, Immunology and Hygiene Medical Department, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Clinics of Erlangen, Erlangen, Germany.

The mycobacterial cord factor trehalose-6,6-dimycolate (TDM) and its synthetic analog trehalose-6,6-dibehenate (TDB) are potent adjuvants for Th1/Th17 vaccination that activate Syk-Card9 signaling in APCs. In this study, we have further investigated the molecular mechanism of innate immune activation by TDM and TDB. The Syk-coupling adapter protein FcRgamma was essential for macrophage activation and Th17 adjuvanticity. The FcRgamma-associated C-type lectin receptor Mincle was expressed in macrophages and upregulated by TDM and TDB. Recombinant Mincle-Fc fusion protein specifically bound to the glycolipids. Genetic ablation of Mincle abolished TDM/TDB-induced macrophage activation and induction of T cell immune responses to a tuberculosis subunit vaccine. Macrophages lacking Mincle or FcRgamma were impaired in the inflammatory response to Mycobacterium bovis bacillus Calmette-Guérin. These results establish that Mincle is a key receptor for the mycobacterial cord factor and controls the Th1/Th17 adjuvanticity of TDM and TDB.

UI MeSH Term Description Entries
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D009163 Mycobacterium bovis The bovine variety of the tubercle bacillus. It is called also Mycobacterium tuberculosis var. bovis. BCG,Calmette-Guerin Bacillus
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003311 Cord Factors Toxic glycolipids composed of trehalose dimycolate derivatives. They are produced by MYCOBACTERIUM TUBERCULOSIS and other species of MYCOBACTERIUM. They induce cellular dysfunction in animals. Trehalose Dimycolates,Cord Factor,Trehalose-6,6'-Dimycolate,Dimycolates, Trehalose,Factor, Cord,Factors, Cord,Trehalose 6,6' Dimycolate
D006017 Glycolipids Any compound containing one or more monosaccharide residues bound by a glycosidic linkage to a hydrophobic moiety such as an acylglycerol (see GLYCERIDES), a sphingoid, a ceramide (CERAMIDES) (N-acylsphingoid) or a prenyl phosphate. (From IUPAC's webpage) Glycolipid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D017452 Receptors, IgG Specific molecular sites on the surface of various cells, including B-lymphocytes and macrophages, that combine with IMMUNOGLOBULIN Gs. Three subclasses exist: Fc gamma RI (the CD64 antigen, a low affinity receptor), Fc gamma RII (the CD32 antigen, a high affinity receptor), and Fc gamma RIII (the CD16 antigen, a low affinity receptor). Antigens, CD16,Antigens, CD32,Antigens, CD64,CD16 Antigens,CD32 Antigens,CD64 Antigen,CD64 Antigens,Fc Gamma Receptor,Fc Receptors, gamma,Fc gamma Receptors,IgG Receptor,IgG Receptors,Leu-11 Antigen,Receptors, Fc gamma,gamma Fc Receptor,gamma Fc Receptors,CD 16 Antigens,CD 32 Antigens,CD 64 Antigens,CDw32 Antigens,Fc gamma RI,Fc gamma RII,Fc gamma RIII,Immunoglobulin G Receptor,Leu-11 Antigens,Antigen, CD64,Antigen, Leu-11,Antigens, CD 16,Antigens, CD 32,Antigens, CD 64,Antigens, CDw32,Antigens, Leu-11,Fc Receptor, gamma,Gamma Receptor, Fc,Leu 11 Antigen,Leu 11 Antigens,Receptor, Fc Gamma,Receptor, IgG,Receptor, Immunoglobulin G,Receptor, gamma Fc,Receptors, gamma Fc,gamma RI, Fc,gamma RII, Fc,gamma RIII, Fc,gamma Receptors, Fc

Related Publications

Hanne Schoenen, and Barbara Bodendorfer, and Kelly Hitchens, and Silvia Manzanero, and Kerstin Werninghaus, and Falk Nimmerjahn, and Else Marie Agger, and Steffen Stenger, and Peter Andersen, and Jürgen Ruland, and Gordon D Brown, and Christine Wells, and Roland Lang
July 2020, Journal of immunology (Baltimore, Md. : 1950),
Hanne Schoenen, and Barbara Bodendorfer, and Kelly Hitchens, and Silvia Manzanero, and Kerstin Werninghaus, and Falk Nimmerjahn, and Else Marie Agger, and Steffen Stenger, and Peter Andersen, and Jürgen Ruland, and Gordon D Brown, and Christine Wells, and Roland Lang
June 2022, Chemical communications (Cambridge, England),
Hanne Schoenen, and Barbara Bodendorfer, and Kelly Hitchens, and Silvia Manzanero, and Kerstin Werninghaus, and Falk Nimmerjahn, and Else Marie Agger, and Steffen Stenger, and Peter Andersen, and Jürgen Ruland, and Gordon D Brown, and Christine Wells, and Roland Lang
January 2018, The open rheumatology journal,
Hanne Schoenen, and Barbara Bodendorfer, and Kelly Hitchens, and Silvia Manzanero, and Kerstin Werninghaus, and Falk Nimmerjahn, and Else Marie Agger, and Steffen Stenger, and Peter Andersen, and Jürgen Ruland, and Gordon D Brown, and Christine Wells, and Roland Lang
April 2013, Immunobiology,
Hanne Schoenen, and Barbara Bodendorfer, and Kelly Hitchens, and Silvia Manzanero, and Kerstin Werninghaus, and Falk Nimmerjahn, and Else Marie Agger, and Steffen Stenger, and Peter Andersen, and Jürgen Ruland, and Gordon D Brown, and Christine Wells, and Roland Lang
December 2009, The Journal of experimental medicine,
Hanne Schoenen, and Barbara Bodendorfer, and Kelly Hitchens, and Silvia Manzanero, and Kerstin Werninghaus, and Falk Nimmerjahn, and Else Marie Agger, and Steffen Stenger, and Peter Andersen, and Jürgen Ruland, and Gordon D Brown, and Christine Wells, and Roland Lang
January 2013, Frontiers in immunology,
Hanne Schoenen, and Barbara Bodendorfer, and Kelly Hitchens, and Silvia Manzanero, and Kerstin Werninghaus, and Falk Nimmerjahn, and Else Marie Agger, and Steffen Stenger, and Peter Andersen, and Jürgen Ruland, and Gordon D Brown, and Christine Wells, and Roland Lang
December 2009, The Journal of experimental medicine,
Hanne Schoenen, and Barbara Bodendorfer, and Kelly Hitchens, and Silvia Manzanero, and Kerstin Werninghaus, and Falk Nimmerjahn, and Else Marie Agger, and Steffen Stenger, and Peter Andersen, and Jürgen Ruland, and Gordon D Brown, and Christine Wells, and Roland Lang
April 2019, Molecular & cellular proteomics : MCP,
Hanne Schoenen, and Barbara Bodendorfer, and Kelly Hitchens, and Silvia Manzanero, and Kerstin Werninghaus, and Falk Nimmerjahn, and Else Marie Agger, and Steffen Stenger, and Peter Andersen, and Jürgen Ruland, and Gordon D Brown, and Christine Wells, and Roland Lang
December 2014, Glycobiology,
Hanne Schoenen, and Barbara Bodendorfer, and Kelly Hitchens, and Silvia Manzanero, and Kerstin Werninghaus, and Falk Nimmerjahn, and Else Marie Agger, and Steffen Stenger, and Peter Andersen, and Jürgen Ruland, and Gordon D Brown, and Christine Wells, and Roland Lang
December 2017, Immunity, inflammation and disease,
Copied contents to your clipboard!